190种化合物对SARS-CoV-2的抑制作用 蛋白质:分子对接相互作用
Gabriella B Souza1, Larissa Sens1, Stefan J Hammerschmidt2
1Department of Chemistry, CFM, Universidade Federal de Santa Catarina, Campus Universitário-Trindade, Florianópolis, Santa Catarina, Brazil.
Archiv der Pharmazie
|May 31, 2023
概括
研究人员选了190种化合物用于SARS-CoV-2 Mpro抑制. 一种西西马巴衍生物表现出强烈的活性,表明有可能开发新的抗病毒药物来对抗COVID-19.
科学领域:
- 药用化学 医学化学
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
背景情况:
- COVID-19仍然是一个全球健康挑战,需要新的抗病毒策略超越疫苗和现有的药物.
- 新出现的SARS-CoV-2变种和当前治疗方法的局限性强调了对新型治疗剂的需求.
- 由于其在病毒复制中的重要作用,SARS-CoV-2主蛋白酶 (Mpro) 是抗病毒药物开发的关键目标.
研究的目的:
- 选各种自然和合成化合物的图书馆,以检测对SARS-CoV-2主要蛋白酶 (Mpro) 的抑制活性.
- 识别具有潜在的新型化学支架,作为对SARS-CoV-2的抗病毒线索.
- 通过分子对接,研究活性化合物与Mpro活性部位的结合相互作用.
主要方法:
- 在体外查190种化合物 (27种天然,163种合成) 针对纯化的SARS-CoV-2 Mpro.
- 活性化合物的抑制常数 (Ki) 值的确定.
- 使用Mpro的晶体结构进行分子对接研究 (PDB ID:5RG1,5RG2,5RG3).
主要成果:
- 25种化合物表现出Mpro抑制活性,其Ki值在23.2至241μM之间.
- 一种特定的 thiosemicarbazone 衍生物成为了在屏幕上发现的最强大的抑制剂.
- 分子对接揭示了Mpro活性部位内的关键相互作用,包括疏水性,键和固体相互作用.
结论:
- 西米巴衍生物显示出有前途的潜力,作为潜在的抗病毒药物,可用于开发针对SARS-CoV-2的新疗法.
- 这些化合物的进一步探索和优化对于治疗开发是有必要的.
- 该研究强调了严格评估的重要性,以避免在药物查中出现假阳性结果.
相关概念视频
Protein-protein Interfaces
12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Factors Affecting Protein-Drug Binding: Drug Interactions
209
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
209
Protein-Drug Binding: Mechanism and Kinetics
668
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
668
Factors Affecting Protein-Drug Binding: Protein-Related Factors
204
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
204


